Shelling out nearly $16,000 for a 14-day course of medication is what to expect for the wholesale cost of Zurzuvae, the first oral treatment for postpartum depression, according to a Nov. 7 news release from drugmaker Sage Therapeutics. 

After a three-day walkout of retail pharmacy employees across the U.S., organizers of the grassroots labor action created an organization that seeks to unionize the workforce and advocate for safer working conditions. 

As 2023 entered its fourth quarter, one cancer drug shortage resolved as more than a dozen continue; a California system helped make a chemotherapy management app; and the FDA approved a new head and neck cancer medication. 

On Nov. 8, the FDA approved Eli Lilly's Zepbound (tirzepatide), a weekly injection for chronic weight management. 

Accord Healthcare, a London-based drugmaker, resumed manufacturing of two methotrexate solutions, according to a Nov. 7 update from the FDA. 

The FDA is investigating reports of hospitalizations tied to suspected counterfeit versions of semaglutide drugs, including three in the U.S., according to records from the agency's adverse event reporting system. 

As hundreds of pharmacy and imaging workers for Kaiser Permanente strike, a spokesperson for the system told CBS affiliate KPIC their union's ask for a 43% raise over the next four years is "frankly, not reasonable."

Pneumonia patients who took an antibiotic that's typically reserved as an alternative were less likely to develop Clostridioides difficile infections compared to those taking the recommended drug, according to a study from Veterans Affairs Hospitals. 

The U.S. healthcare industry could save more than $1.1 trillion and prevent about 15 million heart attacks over the next 30 years if pharmacists were more involved in hypertension care, according to research conducted by Virginia Commonwealth University in Richmond. 

Organizations representing thousands of hospital pharmacies are criticizing CMS' plan to not provide further reimbursement to 340B hospitals after paying a $9 billion lump sum. 

Nurix Therapeutics, a drugmaker based in San Francisco, said the FDA has placed a partial clinical hold on its phase 1 trial for an experimental drug for lymphoma and leukemia. 

Sixteen years after pharmacists from the University of Florida College of Pharmacy in Gainesville petitioned the FDA to require new efficacy studies of an ingredient in decongestants, their efforts came to fruition. In September, an FDA panel unanimously declared the ingredient ineffective. 

Salt Lake City-based Intermountain Health is one of the latest health systems to enter the emerging world of prescription delivery via drone. 

A global study of zoliflodacin, a drug candidate for gonorrhea, found "unprecedented" phase 3 results, its drugmaker said Nov. 1. 

In August, CVS said it would cut about 5,000 jobs, and a few weeks later, its workforce was notified of layoffs in at least nine states. Before Halloween, the retail chain filed more WARN notices. 

The FDA is advising healthcare workers who administer Moderna's COVID-19 pediatric vaccine to only administer 0.25 milliliters instead of the entire vial. 

As the three-day walkouts among CVS, Walgreens and Rite Aid pharmacy employees come to a close, hospital pharmacy leaders shared with Becker's their workforce concerns. 

There's been no way to confirm how many pharmacists and pharmacy technicians have participated at planned walkouts at CVS, Rite Aid and Walgreens locations nationwide, though estimates and reports suggest a quiet turnout. 

Compared to 2022, there is a 15% higher demand for hospital pharmacists so far in 2023, according to a recent report from the American Association of Colleges of Pharmacy. 

Pfizer is shuttering its location in Gladstone, N.J., and the company is offering to relocate the current employees.